Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.accpm.2018.10.012 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum: Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease.
Front Neurol
January 2025
Department of Neurology, University of California, Irvine, Irvine, CA, United States.
[This corrects the article DOI: 10.3389/fneur.2024.
View Article and Find Full Text PDFCorrection: Self-Assembly of Binderless MXene Aerogel for Multiple-Scenario and Responsive Phase Change Composites with Ultrahigh Thermal Energy Storage Density and Exceptional Electromagnetic Interference Shielding.
Nanomicro Lett
January 2025
Key Laboratory of Material Chemistry for Energy Conversion and Storage of Ministry of Education, School of Chemistry and Chemical Engineering, Huazhong University of Science and Technology, Wuhan, 430074, People's Republic of China.
Corrigendum to "Insights into molecular interactions at organic-MBene heterointerfaces for efficient Zn-ion storage" [J. Coll. Inter. Sci. 678(Part B) (2025) 95-104/ YJCIS_35740].
J Colloid Interface Sci
January 2025
School of Electronic and Information Engineering, Hebei University of Technology, Tianjin 300130, China; Hebei Collaborative Innovation Center of Microelectronic Materials and Technology in Ultra Precision Processing, Tianjin 300130, China; Hebei Engineering Research Center of Microelectronic Materials and Devices, Tianjin 300130, China.
Corrigendum to "Home infusion experience in patients with Pompe disease receiving avalglucosidase alfa during three clinical trials" [Molecular Genetics and Metabolism, 143 (2024) 108608].
Mol Genet Metab
January 2025
Center for Lysosomal and Metabolic Diseases, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!